Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live

Guggenheim Partners & Goldman Sachs

8 shared events · Importance 4 · Last updated Aug 05, 2026

Importance
4
Shared Events
8
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
55
Business
Guggenheim Partners: Guggenheim Partners is a joint book-running manager, participating in the offering and earning fees.
Goldman Sachs: Goldman Sachs is a joint book-running manager, earning underwriting fees and enhancing its role in the biotech capital markets.
Aug 04, 2026 · 6 articles
40
Business
Guggenheim Partners: Guggenheim Partners acted as a joint book-running manager, earning underwriting fees.
Goldman Sachs: Goldman Sachs served as a joint book-running manager, benefiting from the successful offering.
Jul 06, 2026 · 25 articles
39
Business
Guggenheim Partners: Guggenheim Partners acted as a bookrunner for the offering.
Goldman Sachs: Goldman Sachs & Co. LLC acted as a joint lead book-running manager for the offering.
Apr 06, 2026 · 8 articles
35
Business
Guggenheim Partners: Guggenheim Securities is a co-global coordinator and joint bookrunner, involved in the IPO.
Goldman Sachs: Goldman Sachs is a joint bookrunner, participating in the underwriting.
Jul 20, 2026 · 6 articles
20
Business
Guggenheim Partners: Guggenheim Securities served as exclusive financial advisor to Forte Biosciences.
Goldman Sachs: Goldman Sachs served as exclusive financial advisor to Argenx.
Jul 27, 2026 · 6 articles
15
Business
Guggenheim Partners: Guggenheim Securities is a joint lead book-running manager for the offering.
Goldman Sachs: Goldman Sachs is a joint lead book-running manager for the IPO.
Apr 20, 2026 · 7 articles
0
Business
Guggenheim Partners: Guggenheim Partners is acting as a joint book-running manager for the public offering of Spyre Therapeutics' common stock.
Apr 13, 2026 · 7 articles
0
Business
Guggenheim Partners: Guggenheim Partners, LLC is serving as a financial advisor to MiNK Therapeutics.
Apr 06, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Guggenheim Partners and Goldman Sachs interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.